Ron Finklestien
Downgrading Charles Schwab
Reconsidering Charles Schwab: Downgrade Amid a Mixed Picture
Every crisis harbors investment opportunities. When the banking crisis erupted last year, my attention was swiftly drawn to the financial sector. Amid this flurry, ...
Is CACI International Set to Rally Around 21%? A Look at 10 Top Analyst Forecasts For Friday
CACI International Set to Rally?
Top Wall Street analysts have adjusted their outlook on various top companies. For a comprehensive view of all analyst rating changes, including upgrades and ...
OneSpan’s Leadership Shake-Up and Financial Projections Update
OneSpan’s Leadership Shake-Up and Financial Projections Update
jittawit.21/iStock via Getty Images OneSpan (NASDAQ:OSPN) fell 2.80% Friday pre-market after the software company announced interim CEO appointment and updated guidance. Victor Limongelli has ...
Insightful Investments: Identifying Potential Stocks in Market Downturn
Insightful Investments: Identifying Potential Stocks in Market Downturn
Today’s episode of Full Court Finance at Zacks dives into the much-needed market pullback to start 2024, and why investors might want to start ...
First Solar Strikes Long-Term PPA Deal With Cleantech Solar
First Solar, Inc. FSLR has successfully sealed a 15-year power purchase agreement (PPA) with Cleantech Solar, marking a significant milestone for the renewable energy ...
Insider Trades: Retractable Technologies and 3 Other Stocks Under $3
Insider Trades: Retractable Technologies and 3 Other Stocks Under $3
The Dow Jones index closed higher by around 10 points on Thursday. Insiders purchasing or selling shares indicates their confidence or concern around the ...
ZIM Integrated Shipping: Seizing the Opportunities of Red Sea Disruptions
ZIM Integrated Shipping: Seizing the Opportunities of Red Sea Disruptions
Note: My previous coverage of ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) sets the stage for this update on the company. In a twist of ...
Theravance Biopharma Faces Setback with Yupelri Trial Results
Theravance Biopharma Faces Setback with Yupelri Trial Results
Photo by mi-viri/iStock via Getty Images Theravance Biopharma (NASDAQ:TBPH) experienced a staggering ~16% decline in premarket trading on Friday following the disappointing revelation that ...
The Golden Egg: Cal-Maine Foods, Inc. Takes the Lead
Amidst the stark and often volatile landscape of the stock market, there emerges a shining beacon: Cal-Maine Foods, Inc. (CALM). This producer of shell ...
Ormat Technologies (ORA) Acquires Renewable Assets for $271M
Ormat Technologies Enlarges Renewable Portfolio with $271M Acquisition
Ormat Technologies, Inc. ORA revealed that it has completed the previously announced acquisition of a portfolio of geothermal and solar assets from Enel Green ...
